Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer

Anticancer Research

Volumn 20, Issue 1 B, 2000, Pages 493-496

  Koomägi, Reet ^a   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Caspase 3; Immunohistochemistry; Lung cancer; Lung cancer cell lines; Metastasis; Prognosis; Survival; Western blotting

Indexed keywords

CASPASE 3;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; TREATMENT OUTCOME; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0342314472     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
2. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
3. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446-448, 1995.
4. Yuan I, Shaham S, Ledoux S, Ellis HM and Horwitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β- converting enzyme. Cell 75: 641-652, 1993.
5. Fernandes- Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
6. Liu X, Zou H, Slaughter C, Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184, 1997.
7. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A, Sakiyama S: High levels of expression and nuclear localization of interleukin-1 β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 20: 4578-4584, 1997.
8. Kondo S, Tanaka Y, Kondo Y, Ishizaka Y, Hitomi M, Haqqi T, Liu J, Barnett GH, Alnemri ES: Retroviral transfer of CPP32 beta gene into malignant gliomas in vitro and in vivo. Cancer Res 5: 962-967, 1998.
9. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Amer Ass 53: 457-481, 1956.
10. Kalbfleisch I, Prendice L: Analysis of failure time data. J. Wiley: New York, 1980.
11. Depraetere V, Golstein P: Dismantling in cell death: molecular mechanisms and relationship to caspase activation. Scand J Immunol 47: 523-531, 1998.
12. Koomägi R, Volm M: Expression of Fas (CD95/APO-1) and Fas-ligand in lung cancer and its prognostic and predictive relevance. Int J Cancer 84: 239-243, 1999.
13. Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Letters 115: 185-193, 1998.
14. Kangas A, Nicholson DW, Hölttä E. Involvement of CPP32/Caspase-3 in c-Myc- induced apoptosis. Oncogene 16: 387-398, 1998.